BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:setrusumab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of setrusumab\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06636071-10813@assetmemo.bio
DTSTAMP:20261121T004025Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:setrusumab: Phase 3 readout est. (NCT06636071)
DESCRIPTION:setrusumab\, phase 3\, Osteogenesis Imperfecta.\nStudy: Setrusu
 mab in Pediatric Japanese Subjects With Osteogenesis Imperfecta\nEstimated
  primary completion: January 2027. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/setrusumab#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT06636071
URL:https://assetmemo.bio/drug/setrusumab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
